This study evaluated the in vitro antifungal activity of the chloroform extract of Plumeria bicolor and its phytoconstituents plumericin and isoplumericin against Candida species and Cryptococcus neoformans by measuring the Minimum Inhibitory Concentration (MIC) and Minimum Fungicidal Concentration (MFC). Plumericin's consistently high activity against Candida albicans, C. krusei, C. glabrata, C. tropicalis and Cryptococcus neoformans was more potent than isoplumericin and the standard antifungal drug nystatin suggesting its potential as a drug candidate for candidiasis and cryptococcosis.
Acquired immunodeficiency syndrome (AIDS) increases the impact of life-threatening fungal infections in immunocompromised patients in spite of new antifungal agents [1a] . Candidiasis, a fungal disease caused by various Candida species such as C. albicans, C. krusei, C. glabrata, and C. tropicalis, has a worldwide distribution [1b] . In India candidiasis appears in approximately 58% of AIDS patients as the first opportunistic infection [1c] . Cryptococcus neoformans is the second most common cause of opportunistic fungal infection in AIDS patients, but also causes disease in normal hosts [2] . Hence, there is an urgent need for new, inexpensive antifungal agents for which plant-derived natural products may offer potential leads [3a] . Recently, plant derived compounds showed anticandidal and anticryptococcal activities [3b].
Plumeria bicolor, commonly known as "Champa", is a well-known Indian medicinal plant containing the iridoid, plumeiride, which is reported to have anticancerous [4a] and antispermatogenic activity [4b]. Plumericin (1) and isoplumericin (2) are iridoids reported to have algicidal [5a] , anti-leishmanial [5b], molluscicidal [5c] and antifungal activity [6] . Testing of the antifungal activity of the chloroform extract of P. bicolor, as well as (1) and (2), against C. albicans, C. krusei, C. glabrata, C. tropicalis and C. neoformans revealed considerable activity as measured by the MIC and MFC values and compared to nystatin (Table 1) . Plumericin showed the most potent anticandidal and anticryptococcal activity compared to the P. bicolor extract, isoplumericin and the standard drug nystatin. The strong activity might be explained by the presence of the α-methylene γ-lactone moiety, which is susceptible to Michael-type addition with biological nucleophiles [5c,7]. 
Experimental

Plant material and Isolation of plumericin & isoplumericin:
The stem bark of Plumeria bicolor was collected from the campus of University of Rajasthan, Jaipur and identified by their Department of Botany (RUBL-20603). Three kilograms of shade dried, powdered bark of P. bicolor was exhaustively extracted at 65°C with methanol for approximately 72 hours. The methanol extract was filtered and evaporated to dryness under reduced pressure in a rotary evaporator at 40°C. The concentrated mass was subsequently extracted with acetonitrile and chloroform. Removal of the chloroform by distillation at 70°C afforded ~30 g. residue. Half of the extract was used for the antifungal assay and half for isolation of compounds 1 and 2 by chromatography on Sigel. Elution with 8:2 chloroform: methanol gave 900 mg plumericin (1) as white crystals mp 210-212°C [9] and 550 mg isoplumericin (2) white crystals mp 196-198°C [9] . NMR and MS values were in agreement with those reported earlier [9, 10] .
Microbial strains and growth condition:
Four standard strains (Table 1) were sub-cultured on SDA and incubated at 37°C for 24-48 hours. The active cultures for experiment were prepared by streaking on SDA and incubated at 37°C for 24 hours. The suspension was adjusted to 70% transmittance by a spectrophotometer at 530 nm, which results in a suspension containing about 1 x 10 6 CFU/mL.
In vitro antifungal assay:
The anti-candidal and anticryptococcal activities of P. bicolor extract, plumericin and isoplumericin were determined by measuring the Minimum Inhibitory Concentration (MIC) and Minimum Fungicidal Concentration (MFC) by the microbroth dilution method according to the CLSI, NCCLS M27-A2 guidelines [11] . Geometric dilutions ranging from 15.6 to 500 µg/mL of P. bicolor extract and from 0.1 to 10 µg/mL of both compounds were prepared in 96-well microtiter plates. The final concentration of each well was adjusted to 1×10 6 CFU/mL cells of C. albicans, C. krusei, C. glabrata, C. tropicalis and C. neoformans and incubated at 37°C for 24 hours (Candida species) or 48 hours (C. neoformans).
The MIC was defined as the lowest concentration of test sample that resulted in complete inhibition of visible growth. The microbial growth was indicated by the presence of a white pellet on the well bottom. Nystatin was used as a reference. The samples and reference were dissolved in DMSO at the same concentration (1%). Aliquots from each of the wells were sub-cultured on SDA plates and incubated for 24 hours (Candida species) and 48 hours (C. neoformans). MFC was determined as the lowest concentration of test samples at which the organisms showed no growth on further sub-culturing on SDA plates. All experiments were repeated three times and median values were calculated by statistical analysis. 
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